Testing a new diabetes medication for people with cystic fibrosis

This trial is testing a medication called dulaglutide to see if it can help improve insulin production in people with cystic fibrosis who have trouble controlling their blood sugar. Cystic fibrosis often damages the pancreas over time, making it harder for the body to manage glucose levels. This study wants to know if the medication can help preserve the pancreas's ability to produce insulin and slow or prevent diabetes from developing.

Diabetes is a serious complication that happens in many people with cystic fibrosis and leads to worse health outcomes. There aren't many good treatment options right now that specifically target the underlying insulin problems in cystic fibrosis, so researchers want to test whether this medication might help protect pancreatic function before diabetes fully develops.